Re: ZHCLF up 290% to $0.16...question
|
1
|
Zenith Epigenetics
|
Dec 11, 2020 03:14PM
|
Re: Looking forward to the short interest update....
|
1
|
Resverlogix Corp.
|
Oct 21, 2019 09:55AM
|
Re: $1.70 close on light volume....
|
1
|
Resverlogix Corp.
|
Nov 15, 2016 05:10PM
|
Re: DrDR Podcast
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 30, 2020 01:55PM
|
Re: Quarterly filings 10/30/17
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jan 19, 2018 06:26AM
|
Re: RVX AGM Q&A, post AGM-huddle, impressions
|
1
|
Resverlogix Corp.
|
Sep 19, 2018 09:01AM
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 25, 2021 07:28AM
|
Re: Travel
|
1
|
Resverlogix Corp.
|
May 10, 2017 01:10PM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
1
|
Resverlogix Corp.
|
Dec 22, 2020 10:04AM
|
Re: Zacks BTI Valuation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 31, 2022 07:47AM
|
Re: ZHCLF
|
1
|
Zenith Epigenetics
|
Jul 26, 2022 06:41AM
|
Re: Gap ups and Gap downs....
|
1
|
Resverlogix Corp.
|
Mar 20, 2017 02:24PM
|
Re: Interesting Observation
|
1
|
Resverlogix Corp.
|
Feb 01, 2018 08:47PM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
1
|
Zenith Epigenetics
|
May 19, 2024 08:53PM
|
Novartis to pay $310 million for assets from inflammation specialist IFM.
|
1
|
Resverlogix Corp.
|
Apr 01, 2019 07:01AM
|
Re: Adjudication
|
1
|
Resverlogix Corp.
|
Jan 29, 2019 07:32PM
|
Re: RVX AGM and Zenith AGM, my thoughts
|
1
|
Resverlogix Corp.
|
Sep 12, 2016 09:30PM
|
Re: rumours have been flying around the last ...
|
1
|
Zenith Epigenetics
|
Mar 01, 2021 06:40AM
|
Re: ...3 trading days left..
|
1
|
Resverlogix Corp.
|
Oct 17, 2015 07:02AM
|
Re: 2018
|
1
|
Resverlogix Corp.
|
Mar 04, 2016 05:53PM
|